153439-40-8

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

81 API Suppliers, 24 USDMF, 12 CEP/COS, 15 JDMF, 13 EU WC, 9 KDMF, 23 NDC API, 50 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

26 API Suppliers

26 API Suppliers

FINISHED DOSAGE FORMULATIONS

285 FDF Dossiers, 96 FDA Orange Book, 76 Europe, 4 Canada, 5 Australia, 30 South Africa, 74 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 30MG/5ML, TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG, TABLET;ORAL - 180MG, TABLET;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 60MG, TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG, TABLET, ORALLY DISINTEGRATING;ORAL - 30MG, SUSPENSION;ORAL - 30MG/5ML

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Rochem International Inc, 18 SPI Pharma, 2 Seqens, 11 DKSH, 3 Jai Radhe Sales, 2 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 15 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 36 BASF, 1 Bioplus Life Sciences, 1 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 37 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

113 Fillers, Diluents & Binders, 59 Coating Systems & Additives, 55 Direct Compression, 44 Disintegrants & Superdisintegrants, 44 Thickeners and Stabilizers, 36 Granulation, 36 Controlled & Modified Release, 32 Solubilizers, 31 Taste Masking, 29 Lubricants & Glidants, 28 Film Formers & Plasticizers, 23 Chewable & Orodispersible Aids, 22 Topical, 21 Parenteral, 21 Co-Processed Excipients, 9 API Stability Enhancers, 9 Empty Capsules, 8 Emulsifying Agents, 7 Rheology Modifiers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 28 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

74 Finished Drug Prices, 9 Annual Reports

MARKET PLACE

32 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 13 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 3 USP, 4 JP, 6 Others

ANALYTICAL

1 BioAnalytical Methods, 5 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 201373 / DOSAGE - SUSPENSION;ORAL - 30MG/5ML

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
FEXOFENADINE HYDROCHLORIDE(UNII: 2S068B75ZU) (FEXOFENADINE - UNII:E6582LOH6V)	FEXOFENADINE HYDROCHLORIDE	30mg in 5 \| 30mg in 5

Inactive Ingredients

Ingredient Name	sanofi-aventis U.S. LLC	Actavis Pharma, Inc.	Cardinal Health, Inc.	Chain Drug Consortium, LLC	CVS Pharmacy	HEB	Kroger Company	Meijer Distribution Inc	Rite Aid	Rugby Laboratories	Supervalu Inc	Topco Associates LLC	Wal-Mart Stores Inc	Walgreen Company	Chattem, Inc.
anhydrous citric acid(XF417D3PSL)
aspartame(Z0H242BBR1)
BUTYLPARABEN(3QPI1U3FV8)
cellulose acetate(3J2P07GVB6)
cellulose, microcrystalline(OP1R32D61U)
croscarmellose sodium(M28OL1HH48)
crospovidone(68401960MK)
EDETATE DISODIUM(7FLD91C86K)
hypromelloses(3NXW29V3WO)
magnesium stearate(70097M6I30)
mannitol(3OWL53L36A)
POLOXAMER 407(TUF2IVW3M2)
polyethylene glycols(3WJQ0SDW1A)
POTASSIUM SORBATE(1VPU26JZZ4)
povidone K30(U725QWY32X)
povidone(FZ989GH94E)
PROPYLENE GLYCOL(6DC9Q167V3)
PROPYLPARABEN(Z8IX2SC1OH)
silicon dioxide(ETJ7Z6XBU4)
sodium bicarbonate(8MDF5V39QO)
sodium chloride(451W47IQ8X)
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS(22ADO53M6F)
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE(70WT22SF4B)
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS(KH7I04HPUU)
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE(593YOG76RN)
SUCROSE(C151H8M554)
TITANIUM DIOXIDE(15FIX9V2JP)
WATER(059QF0KO0R)
XANTHAN GUM(TTV12P4NEE)
XYLITOL(VCQ006KQ1E)

Drug Product Composition: 153439-40-8

153439-40-8

153439-40-8

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

81 API Suppliers

24 USDMF

12 CEP/COS

15 JDMF

13 EU WC

9 KDMF

23 NDC API

50 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

26 API Suppliers

FINISHED DOSAGE FORMULATIONS

285 FDF Dossiers

96 FDA Orange Book

76 Europe

4 Canada

5 Australia

30 South Africa

74 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 30MG/5ML

TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG

TABLET;ORAL - 180MG

TABLET;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 60MG

TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG

TABLET, ORALLY DISINTEGRATING;ORAL - 30MG

SUSPENSION;ORAL - 30MG/5ML

RELATED EXCIPIENT COMPANIES

1 Minakem

6 Rochem International Inc

18 SPI Pharma

2 Seqens

11 DKSH

3 Jai Radhe Sales

2 Pharm-RX Chemical

10 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

15 Gangwal Healthcare

8 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 ACG Worldwide

12 Actylis

1 Aeon Procare

3 Alcedo Pharmachem

11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

36 BASF

1 Bioplus Life Sciences

1 Clariant

11 Corel Pharma Chem

7 DFE Pharma

2 Finar

12 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

5 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

37 Kerry

4 Kima Chemical

6 Lonza Capsugel

18 Microlex e.U

2 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

4 Novo Excipients

TABLET;ORAL - 30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons